ArticleCancers2025

An In Silico Feasibility Study of Dose-Escalated Hypofractionated Proton Therapy for Rectal Cancer.

Erik Almhagen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.